Walleye Capital
DVAX

Walleye Capital’s Dynavax Technologies DVAX Stock Holding History

Walleye Capital’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-101,970
Closed -$1.57M – 4531
2025
Q4 		$1.57M Buy
+101,970
New +$1.12M ﹤0.01% 2059
2025
Q2 		– Sell
-266,879
Closed -$3.46M – 4614
2025
Q1 		$3.46M Buy
266,879
+258,154
+2,959% +$3.42M 0.02% 1034
2024
Q4 		$111K Sell
8,725
-73,243
-89% -$886K ﹤0.01% 4092
2024
Q3 		$913K Buy
81,968
+21,245
+35% +$234K ﹤0.01% 2743
2024
Q2 		$682K Buy
60,723
+24,271
+67% +$283K ﹤0.01% 3219
2024
Q1 		$452K Buy
+36,452
New +$475K ﹤0.01% 3280
2020
Q3 		– Sell
-50,943
Closed -$452K – 866
2020
Q2 		$452K Buy
+50,943
New +$257K 0.1% 245
2019
Q3 		– Sell
-76,000
Closed -$303K – 1964
2019
Q2 		$303K Buy
+76,000
New +$441K 0.03% 730

Other funds holding DVAX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Walleye Capital's DVAX Position: Q1 2026 in Review

Walleye Capital sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 101,970 shares — an estimated $1.57M sold.

Walleye Capital first reported a position in DVAX in Q2 2019 and held it in 8 quarters. The position peaked at $3.46M in Q1 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Walleye Capital reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 101,970 Dynavax Technologies shares in Q1 2026, an estimated $1.57M.
  • Walleye Capital first reported a position in Dynavax Technologies in Q2 2019 and held it in 8 quarters.
  • Walleye Capital's Dynavax Technologies position peaked at $3.46M in Q1 2025.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.